The increasing need for effective waste management is a key factor driving the global sharps containers, says Fortune Business Insights in a report, titled “Sharps Containers Market Size, Share & Industry Analysis, By Product Type (Multipurpose Containers, Patient Room Containers, Phlebotomy Containers), By Waste Generators (Hospitals, Other Healthcare Providers, Pharmacies, Academic & Research Institutes, Pharmaceutical Companies, and Others), By Usage (Reusable Containers, and Single Use Containers), By Waste Type (Sharps Waste, Infectious Waste, Non-infectious Waste, and Pharmaceutical Waste), By Size (1–2 Gallons, 2–4 Gallons, 4–8 Gallons and Others) and Regional Forecast, 2019-2026.” The global sharps containers market was valued at USD 449.1 Million in 2018 and is expected to reach USD 624.1 Million by 2026 at a CAGR of 4.2%.
Get Sample PDF Brochure @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sharps-containers-market-101499
“The major players operating in the global sharps containers market are”
- Sharps Compliance, Inc.
- EnviroTain, LLC.
- Bondtech Corporation
- MAUSER Group
- Daniels Healthcare Group
- Henry Schein, Inc.
- Thermo Fisher Scientific Inc.
- GPC Medical
As per the report, the rising awareness regarding hazardous waste is expected to aid the growth of the global sharps containers market. For instance, according to World Health Organization, every year, 16 million injections are used worldwide but lack proper disposal of the same. Additionally, out of the total medical waste generated, 85% consists of general, non-hazardous waste and 15% of hazardous waste. This generated waste contains harmful microorganisms that pose a threat to the environment as well as to the healthcare professionals.
Partnership of PureWay With Safe Needle Disposal Will Favor Growth
PureWay, a health-focused organization specializing in medical waste management and compliance solutions, announced its partnership with Safe Needle Disposal, a non-profit devoted to educating the public about safe needle disposal programs. At-home sharps injectors will give access to a user-friendly informational resource and regulatory experts to help answer all their sharps-related questions. It will also responsibly and affordably dispose of needles with new Safe Needle Disposal. The introduction of At-home sharps injectors will support the global sharps containers growth during the forecast period.
Furthermore, the acquisition of Daniels Healthcare Group by MAUSER is expected to create new growth opportunities for the global sharps containers market. For Instance, MAUSER Group announced the acquisition of Daniels Healthcare Group. Daniels Healthcare manufactures and markets medical waste containers for hospitals, surgeries, and the clinical waste industry.
By Product Type
- Multipurpose Containers
- Patient Room Containers
- Phlebotomy Containers
By Waste Generators
- Other Healthcare Providers
- Academic & Research Institutes
- Pharmaceutical Companies
- Reusable Containers
- Single Use Containers
By Waste Type
- Sharps Waste
- Infectious Waste
- Non-infectious Waste
- Pharmaceutical Waste
- 1–2 Gallons
- 2–4 Gallons
- 4–8 Gallons
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Rising Government Initiatives Regarding Medical Waste Management Will Enable Growth”
The rising need for effective medical waste management is expected to boost the global sharps containers market revenue during the forecast period. The increasing government efforts in implementing guidelines for effective disposal of medical waste will stimulate the growth of the global sharps containers market. For instance, World Health Organization (WHO) along with other regulatory bodies in the countries worldwide, have set standard guidelines for disposal and management of biomedical waste. It has become a mandate for all the pharmaceutical companies, research institutes, hospitals, and other healthcare providers to comply with the set of guidelines given by the governing bodies.
More Trending Topics from Fortune Business Insights: